scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9378(99)70630-7 |
P698 | PubMed publication ID | 10329891 |
P50 | author | Melania Amorim | Q77755331 |
P2093 | author name string | A Faúndes | |
L C Santos | |||
P2860 | cites work | Antenatal corticosteroid prescribing: setting standards of care | Q40874777 |
A case report of maternal death associated with betamimetics and betamethasone administration in premature labor | Q42241027 | ||
Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial | Q46373794 | ||
Maternal administration of dexamethasone in severe pregnancy-induced hypertension | Q70578102 | ||
Cardiovascular response and complications of glucocorticoid therapy in hypertensive pregnancies | Q71675563 | ||
Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes | Q72414034 | ||
Fetal lung maturity is not accelerated in preeclamptic pregnancies | Q72602381 | ||
Pregnancy-induced hypertension and hyaline membrane disease | Q73575162 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
maternal health | Q6786626 | ||
P304 | page(s) | 1283-1288 | |
P577 | publication date | 1999-05-01 | |
P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
P1476 | title | Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia | |
P478 | volume | 180 |
Q37542495 | A conference report on prenatal corticosteroid use in low- and middle-income countries |
Q33948316 | Antecedents of cerebral palsy in very low-birth weight infants |
Q26769708 | Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis |
Q96229858 | Antenatal corticosteroids and preterm offspring outcomes in hypertensive disorders of pregnancy: A Japanese cohort study |
Q24245169 | Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth |
Q30400140 | Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. |
Q34250646 | Antenatal corticosteroids for fetal lung maturation in threatened preterm delivery: indications and administration |
Q46301882 | Antenatal corticosteroids for women at risk of imminent preterm birth in low-resource countries: the case for equipoise and the need for efficacy trials |
Q38281536 | Antenatal glucocorticoids: where are we after forty years? |
Q54723347 | Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. |
Q24613198 | Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth |
Q54990701 | Association between the high soluble fms-like tyrosine kinase-1 to placental growth factor ratio and adverse outcomes in asymptomatic women with early-onset fetal growth restriction. |
Q90101191 | Association of Maternal Preeclampsia with Neonatal Respiratory Distress Syndrome in Very-Low-Birth-Weight Infants |
Q34705137 | Australasian randomised trial to evaluate the role of maternal intramuscular dexamethasone versus betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability (A*STEROID): study protocol |
Q30558004 | Born too soon: care during pregnancy and childbirth to reduce preterm deliveries and improve health outcomes of the preterm baby |
Q46351013 | Criteria of pregnancy termination in women with preeclampsia |
Q34785352 | Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial |
Q92697645 | Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically-Based Pharmacokinetic Modeling |
Q33334624 | HELLP syndrome |
Q46322372 | Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term |
Q38256857 | Infants at risk of cerebral palsy: a systematic review of outcomes used in Cochrane studies of pregnancy, childbirth and neonatology. |
Q27007059 | Is inflammation the cause of pre-eclampsia? |
Q37709901 | Judicious use of antenatal glucocorticoids: putting the risks into the balance |
Q80948590 | Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement |
Q30234715 | Outcome reporting across randomised controlled trials evaluating therapeutic interventions for pre-eclampsia: a systematic review |
Q38263967 | Outcomes of expectant management after betamethasone for hypertensive disorders of pregnancy |
Q81446389 | Pre-eclampsia |
Q35141777 | Pre-eclampsia: pathophysiology, diagnosis, and management |
Q89319637 | Respiratory Compliance in Late Preterm Infants (340/7-346/7 Weeks) after Antenatal Steroid Therapy |
Q34086090 | Risks and benefits of therapies for apnoea in premature infants |
Q37859881 | Role of fetal sex in the outcome of antenatal glucocorticoid treatment to prevent respiratory distress syndrome: systematic review and meta-analysis. |
Q21261342 | The HELLP syndrome: clinical issues and management. A Review |
Q33990742 | The detection, investigation and management of hypertension in pregnancy: full consensus statement |
Q36131296 | The elevation in circulating anti-angiogenic factors is independent of markers of neutrophil activation in preeclampsia |
Q48146361 | Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction |
Q39107351 | Use of antenatal corticosteroids in special circumstances: a comprehensive review |
Q33198560 | Use of steroids in the perinatal period. |
Q54665570 | Use or overuse of antenatal corticosteroids for suspected preterm birth. |
Search more.